① Shenzhen Invest obtained a financing loan of 2 billion Hong Kong dollars, how long is the term?
The following are important announcements for today's Hong Kong stocks:
1) Company News
$IMMUNEONCO-B (01541.HK)$Announced the global registration strategy for IMM2510 for the treatment of non-small cell lung cancer and triple-negative breast cancer.
The announcement stated that the company is accelerating the development of IMM2510/SYN-2510 for first-line NSCLC, with the goal of initiating a Phase 1b/2 trial of first-line chemotherapy combination therapy in China by the end of 2024. The company is also accelerating the development of IMM2510/SYN-2510 for first-line TNBC, with the goal of initiating a Phase 1b/2 trial of combination chemotherapy in China by early 2025. Instil is prioritizing the development of SYN-2510/IMM2510 for NSCLC and TNBC in the United States, with the goal of submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration by the end of 2024.
$KAISA GROUP (01638.HK)$ : Holders of approximately 75.11% of the total outstanding principal amount of debt within Kaisa Group and approximately 81.07% of the total outstanding principal amount of debt within Ruijing have joined the restructuring support agreement.
$SHENZHEN INVEST (00604.HK)$ : The company has entered into a financing agreement with a bank for a term loan financing of up to HK$2 billion, with a financing period of 36 months.
$CHU KONG SHIP (00560.HK)$: The Pearl River Inland will acquire 51% equity interest in Kaiping Shipping Company for RMB 0.114 billion through capital increase and equity injection.
$DEXIN CHINA (02019.HK)$: No commitments or formal agreements have been reached or signed regarding its potential restructuring, and the trading halt continues.
2) Repurchase Dynamics
$TENCENT (00700.HK)$: Invest HKD 1.003 billion to repurchase 2.67 million shares at a repurchase price of HKD 370.60-377.80.
$AIA (01299.HK)$: Invest HKD 61.3418 million to repurchase 1.12 million shares at a repurchase price of HKD 54.55-55.15.
$BABA-W (09988.HK)$: On September 13, invest USD 59.9816 million to repurchase 5.676 million shares at a repurchase price of USD 10.48-10.61.
$SINOPEC CORP (00386.HK)$: Invest HKD 56.0107 million to repurchase 12.782 million shares at a repurchase price of HKD 4.31-4.41.
$CSPC PHARMA (01093.HK)$Incurring an investment of HKD 49.3281 million to repurchase 10.684 million shares at a repurchase price of HKD 4.51-4.68.
Editor/Lambor